Complexation and solubility behavior of albendazole with some cyclodextrins

Pharmaceutical Development and Technology

Volumn 3, Issue 3, 1998, Pages 395-403

  Díaz, David ^a   Bernad Bernad, Ma Josefa ^a   Mora, Jesús Gracia ^a   Escobar Llanos, Carolina Marta ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Albendazole; Binding constants; Cyclodextrin ( , , , and HP CDs); PH effect; Solubility behavior; Temperature effect

Indexed keywords

ALBENDAZOLE; CYCLODEXTRIN DERIVATIVE; EXCIPIENT;

ABSORPTION SPECTROSCOPY; ARTICLE; COMPLEX FORMATION; DRUG FORMULATION; DRUG SOLUBILITY; HYDROPHOBICITY; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

EID: 0031657030     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459809009867     Document Type: Article

References (26)

1. S. Sharma, Drugs for parasitic diseases, Drugs Today, 25(4), 249-261 (1989).
2. G. Edwards and A. M. Breckenridge, Clinical pharmacokinetics of anthelmintic drugs, Clin. Pharmacokinet., 15, 67-93 (1988).
3. Y. Nakai, A. Aboutaleb, K. Yamamoto, S. Y. Saleh, and M. O. Ahmed, Study of the interaction of clobazan with cyclodextrins in solution and in the solid state, Chem. Pharm. Bull., 38(3), 728-732 (1990).
4. K. Uekama, S. Narisawa, F. Hirayama, and M. Otagiri, Improvement of dissolution and absorption characteristics of benzodiazepines by cyclodextrin complexation, Int. J. Pharm., 16, 327-338 (1983).
5. G. Puglisi, N. A. Santagati, R. Pignatello, C. Ventura, F. A. Bottino, S. Mangiafico, and G. Mazzone, Inclusion complexation of 4-biphenylacetic acid with β-CD, Drug Dev. Ind. Pharm., 16, 395-413 (1990).
6. G. Puglisi, N. A. Santagati, C. Ventura, R. Pignatello, A. M. Panico, and S. Spampinato, Enhancement of 4-biphenylacetic acid bioavailability in rats by its β-CD complex after oral administration, J. Pharm. Pharmacol., 43, 430-432 (1991).
7. T. Tokumura, Y. Tsushima, K. Tatsuishi, M. Kayano, Y. Machida, and T. Nagai, Evaluation of bioavailability upon oral administration of cinnarizine β-CD inclusion complex to beagle dogs, Chem. Pharm. Bull., 33, 2962-2967 (1985).
8. F. Castelli, G. Puglisi, G. Giammona, and C. A. Ventura, Effect of the complexation of some nonsteroidal antiinflammatory drugs with β-CD on the interaction with phosphatidylcholine liposomes, Int. J. Pharm., 88, 1-8 (1992).
9. J. Szejtli, Cyclodextrin Technology, Kluwer, Dordrecht, 1988.
10. T. Higuchi and K. A. Connors, Phase solubility techniques, Adv. Anal. Chem. Instr., 4, 117 (1965).
11. J. Ramírez López, A. Cerezo Galán, and Y. C. Rodríguez Gatán, Aspectos cinéticos de complejos de inclusión con ciclodextrinas, Cienc. Ind. Farm., 6, 325-332 (1987).
12. S. M. Ahmed, A. Naggi, M. Guerrini, and B. Focher, Inclusion complexes of bropirimine with β-CD in solution and in solid state, Int. J. Pharm., 77, 247-254 (1991).
13. F. A. Menard, M. G. Dedhiya, and C. T. Rhodes, Studies of the effect of pH, temperature and ring size on the complexation of phenytoin with cyclodextrins, Pharm. Acta Helv., 63(11), 303-308 (1988).
14. K. A. Connors and J. A. Mollica, Theoretical analysis of comparative studies of complex formation, J. Pharm. Sci., 55, 772 (1966).
15. D. A. Deranleau, Theory of the measurement of weak molecular complexes. I. General considerations, J. Am. Chem. Soc., 91(15), 4044-4049 (1969).
16. C. T. Klein, G. Kholer, B. Mayer, K. Hraz, S. Reiter, H. Viernstein, and P. Wolschann, Solubility and molecular modeling of triflumizole-β-cyclodextrin inclusion complexes, J. Incl. Phenom. Molec. Recog. Chem., 22, 15-32 (1995).
17. G. Fronza, A. Mele, E. Redenti, and P. Ventura, 1H NMR and molecular modeling study on the inclusion complex β-cyclodextrin-indomethacin, J. Org. Chem., 61, 904-914 (1996).
18. J. Szejtli, Cyclodextrin, properties and applications, Drug Invest., 2, 11-21 (1990).
19. F. García Sánchez, M. Hernández, and J. C. Márquez, Thermodynamic study of the β-cyclodextrin benzyl-2-pyridyl ketone 2-pyridyl hydrazone inclusion process, J. Incl. Phenom. Mol. Recog. Chem., 8, 389-394 (1990).
20. F. Cramer and W. Kampe, Inclusion compounds XVII. Catalysis of decarboxylation by cyclodextrins. A model reaction for the mechanism of enzymes, J. Am. Chem. Soc., 87, 1115-1120 (1964).
21. A. Marini, V. Berbenni, and M. Villa, Dehydration of the cyclodextrins: A model system for the interaction of biomolecules with water, J. Chem. Phys., 103, 7532-7540 (1995).
22. R. J. Bergeron and M. P. Meely, The role of strain energy in cycloamylose substrate complexation, Bioorg. Chem., 5, 197-202 (1976).
23. S. Andini, G. Castronuovo, V. Elia, and E. Gallotta, Inclusion compounds in water: calorimetric and spectroscopic studies of the interaction of α-CD with alkanols at 25°C, Carbohydr. Res., 217, 87-97 (1991).
24. W. P. Jencks, Catalysis in Chemistry and Enzimology, Dover Publications, New York, 1987.
25. R. J. Bergeron, Cycloamylose-substrate binding, in Inclusion Compounds. Physical Properties and Applications, Vol. 3 (J. L. Atwood, J. E. D. Davies, and D. D. MacNicol, eds.), Academic Press Inc., London, 1984, pp. 391-443.
26. A. F. Danil de Namor, R. Traboulssi, and D. F. V. Lewis, Host properties of cyclodextrins toward anion constituents of antigenic determinants. A thermodynamic study in water and in N,N-dimethylformamide, J. Am. Chem. Soc., 112, 8442-8447 (1990).